Publikace
- Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women2003 | 1. lékařská fakulta
- The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status2003 | 1. lékařská fakulta
- The influence of vitamin D deficiency and hormonal status on response of bone to ibandronate in patients with klinefelter's syndromePublikace bez příslušnosti k fakultě
- Intermittent intravenous ibandronate injections: a new therapeutic option for preventing postmenopausal bone lossPublikace bez příslušnosti k fakultě
- Intravenous ibandronate injections are at least as effective as daily oral ibandronate: consistent effect across subgroupsPublikace bez příslušnosti k fakultě
- Monthy oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis: 1-year results from mobilePublikace bez příslušnosti k fakultě
- Růstový hormon a kostní tkáň2006 | 1. lékařská fakulta
- Osteoporóza u mužů2006 | 1. lékařská fakulta
- No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in caucasian females2006 | 1. lékařská fakulta
- The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis2006 | 1. lékařská fakulta
Loading network view...